Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging.

Added 2264 days ago (15.07.2015)
Authors: Lowy DR, Herrero R, Hildesheim A, Participants in the IARC/NCI workshop on Primary Endpoints for Prophylactic HPV Vaccine Trials
PubMed id: 25943067
Read article